Two AI-powered platforms for comprehensive ophthalmic screening — from high-volume population programs to specialist-grade diagnostics.

VUNO Fundus AI

Diabetic retinopathy detection, glaucoma suspects, age-related macular degeneration (AMD) — specialist-grade diagnostics at scale.

RetinaLyze AI

Population-level screening, high-volume throughput, rapid turnaround — designed for national and large-scale screening programs.

Diabetic Retinopathy Detection

A leading cause of preventable blindness. Capnova's AI platforms enable early detection at scale.

60%
Faster Diagnosis

AI-powered screening accelerates diagnosis and enables earlier intervention for better patient outcomes.

Bring AI-powered ophthalmology screening to your program.

From population-level programs to specialist clinics — we have the right platform.

Schedule an Ophthalmology AI Briefing